Below are articles from various sources about members of MCB and their research.
On April 15, 2018, the campus community lost a great friend when Professor George Oster passed away in his Berkeley home at the age of 77. Professor Oster was affiliated with many departments on campus, including the MCB division of Cell and Developmental Biology.
Oster's career meandered among many different scientific disciplines, from mechanical engineering to entomology. He spent much of his career investigating the laws of mechanochemical coupling in cells, which led to a significant breakthrough in our understanding of energy transduction as it occurs in living organisms.
MCB, Chemistry & NST Associate Professor Daniel Nomura and MCB & Chemistry Professor Chris Chang partner with Novartis Pharmaceuticals to identify and utilize new drug targets in the human proteome.
These new advancements in chemoproteomics could increase drug efficacy and open up new protein sites for targeted drug treatment.
Industry-minded MCB students and postdocs were enthusiastic about the opportunity to meet industry representatives and ask questions about careers in biotech at the recent MCB Industrial Affiliates Program event on April 10, 2018.
This semester MCB faculty, staff, and students have been working on an equity and inclusion grant we received from the PATH to Care Center on campus. Our goal is to raise awareness about positive social norms and promote an inclusive culture in biology.
KQED's 'Deep Look' web series recently featured leeches from the lab of MCB Professor David Weisblat. Learn more about how these creepy crawlers are being used in surgeries in the clip below!
MCB graduate students Ze Cheng and George Otto are co-lead authors on a new study published in Cell. Their research reports the widespread use of an unconventional mode of gene regulation that employs “transcript toggling” to drive up- and down-regulation of protein levels during meiotic differentiation.
MCB Professor Daniel Portnoy has been selected to become a fellow of the prestigious National Academy of Inventors (NAI). The fellowship is in recognition of Portnoy's research in microbial pathogenesis and significant contributions to the improvement of cancer immunotherapies and vaccine development.